Company Performance: Revenue, profit margins, and earnings per share directly impact investor confidence and stock valuation. Strong financials typically lead to higher prices.

Industry Trends: The overall health and growth prospects of the pharmaceutical industry, including innovation and regulatory changes, influence stock performance.

Market Sentiment: General economic conditions, investor optimism or pessimism, and global events can create volatility and affect all stocks, including 603053.SHG.

Regulatory Environment: Government policies related to drug pricing, approvals, and healthcare reform can significantly alter the profitability and attractiveness of pharmaceutical companies.

Competition: The competitive landscape, including the emergence of new therapies or generic alternatives, can erode market share and impact revenue.

Innovation and Pipeline: Successful development and commercialization of new drugs or innovative technologies can drive stock price appreciation.

Financial News: Announcements such as earnings reports, mergers and acquisitions, and product approvals can lead to immediate price fluctuations.

Macroeconomic Factors: Interest rates, inflation, and currency exchange rates can impact business costs and overall market valuations.

Specific Company News: Unique events affecting the specific company, such as legal challenges, significant contract wins, or management changes, will directly influence the stock price.